Document is current
Any future updates will be listed below
-
Authors
Choudhry, Hassaam S.
Kuklinski, Eric J.
Fu, Allen
Shukla, Param
Montani, Matthew
Eraky, Fareeda
Zarbin, Marco A.
Langer, Paul D.
Bhagat, Neelakshi
- License Information
-
More Information
Article History
Received: 27 July 2024
Accepted: 19 January 2025
First Online: 29 January 2025
Declarations
:
: Marco A Zarbin is a consultant at Boerhinger Ingelheim, EdiGene, Genentech/Roche, Illuminare, Life Biosciences, Novartis Pharma AG, Perfuse Therapeutics, Seeing Medicines, Smile Biotech, Tamarix, and Tenpoint. Marco A Zarbin has equity in NVasc. No other authors have any financial disclosures.
